A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HR011408 at Two Formulations in Healthy Subject
Clinical trial NCT05147259 · COMPLETED
Trial details
- NCT number
- NCT05147259
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-26
- Primary completion
- 2022-01-22
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.